主动脉成角对开窗分支腔内修复术结局的影响
本研究回顾性分析了298例接受开窗分支腔内修复术的胸腹主动脉瘤或肾旁主动脉瘤患者,评估肾下、肾上及腹腔干上主动脉成角是否影响早中期结局。结果显示,肾上主动脉成角>45°是靶血管不稳定的独立危险因素,但整体移植物相关并发症未增加;任何成角>45°均延长手术和透视时间。
要点
- 肾上主动脉成角>45°与靶血管不稳定风险显著增加相关(HR 5.6)。
- 主动脉成角>45°不影响技术成功率及移植物相关并发症。
- 任何主动脉成角>45°均延长手术时间和透视时间。
核心结论
- 开窗分支腔内修复术在主动脉成角>45°患者中可获得良好的早中期结果,不增加移植物相关并发症。
- 肾上主动脉成角是靶血管事件的最重要决定因素,独立于支架设计或桥接支架选择。
研究设计与样本
- 回顾性分析前瞻性非随机医师发起的研究性器械豁免研究(2013-2018)中连续入组患者的数据。
- 共298例患者,其中肾旁主动脉瘤102例(34%),胸腹主动脉瘤196例(66%)(IV extent 78例,I-III extent 118例),共 incorporated 1156条肾-肠系膜血管。
主要发现
- 肾下主动脉轴成角>45°者94例(32%),肾上轴39例(13%),腹腔干上轴93例(31%)。
- 技术成功率为97%,与主动脉成角无显著相关。
- 42个月时免于移植物相关并发症为93%(95%CI 90%-97%),与肾下、肾上或腹腔干上主动脉成角>45°无关。
- 42个月时总体免于靶血管不稳定为92%(95%CI 90%-94%)。
- 多变量分析显示靶血管不稳定与肾上主动脉成角>45°相关(HR 5.6;95%CI 3.5-9.1;P < .001),而与肾下(HR 1.5;95%CI 0.9-2.4;P = .135)和腹腔干上(HR 0.9;95%CI 0.5-1.5;P = .627)成角>45°无关。
临床怎么用
- 对于肾上主动脉成角>45°的患者,应加强术后靶血管监测。
- 主动脉成角>45°患者手术和透视时间较长,需做好相应准备。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the effect of aortic angulation on the early and midterm outcomes of fenestrated-branched endovascular aneurysm repair for thoracoabdominal aortic aneurysms (TAAA) or pararenal aortic aneurysms (PRAA). METHODS: We retrospectively reviewed the data of consecutive patients enrolled in a prospective nonrandomized physician-sponsored investigational device exemption study (2013-2018). The infrarenal, suprarenal, and supraceliac aortic angles were measured on three-dimensional reconstructions of the preoperative computed tomography angiogram; a 45° cutoff was used for the analysis. End points were technical success, freedom from endograft-related complications (defined by type IA/IB/IIIA/IIIB/IIID endoleaks, and limb thrombosis); and freedom from target vessel instability (defined by branch-related death, occlusion, rupture or reintervention for stenosis, endoleak, or disconnection). Cox proportional hazard multivariable regression analyses were preformed to assess impact of covariates. RESULTS: There were 298 patients treated for 102 PRAAs (34%) and 196 TAAAs (66%) (78 extent IV, 118 extent I-III) with 1156 renal-mesenteric vessels incorporated. An angulation of >45° was present in the infrarenal aortic axis in 94 patients (32%), suprarenal axis in 39 (13%), and supraceliac axis in 93 (31%). A supraceliac angle of >45° was more common with extent I-III TAAAs (P = .01). Technical success was 97% and was not significantly related to aortic angulation; the total operating time and fluoroscopy time were significantly longer in patients with any aortic angulation of >45°. Freedom from endograft-related complications was 93% (95% confidence interval [CI], 90%-97%) at 42 months, and was not associated with infrarenal (HR, 1.0; 95% CI, 0.4-2.9; P = .976), suprarenal (HR, 1.7; 95% CI, 0.5-1.8; P = .428), or supraceliac (HR, 0.9; 95% CI, 0.3-2.6; P = .886) aortic angles of >45°. Overall freedom from target vessel instability was 92% (95% CI, 90%-94%) at 42 months. By multivariable analysis, target vessel instability was not affected by an infrarenal angle of >45° (HR, 1.5; 95% CI, 0.9-2.4; P = .135) and a supraceliac angle of >45° (HR, 0.9; 95% CI, 0.5-1.5; P = .627), but was associated with a suprarenal angle of >45° (HR, 5.6; 95% CI, 3.5-9.1; P < .001), even after adjustment for aneurysm extent and type of bridging stent. In this subgroup of patients, the use of directional branch vs fenestration (P = .10) and the type of bridging stent (P = .10) did not significantly impact target vessel instability. CONCLUSIONS: Fenestrated-branched endovascular aneurysm repair can achieve excellent early and midterm results among patients with an aortic angulation of >45°, with no increase in rates of graft-related complications. However, increased aortic angulation was associated with longer operative and fluoroscopy times. The suprarenal aortic angle was the most important determinant of more target vessel events, independent of stent design or which bridging stent was selected.
引用
- Squizzato F, Oderich GS, Balachandran P, et al. Effect of aortic angulation on the outcomes of fenestrated-branched endovascular aortic repair. J Vasc Surg. 2021. PMID: 33548434. doi:10.1016/j.jvs.2021.01.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。